Lymphoma management study at Nimes Hospital (1999-2018)
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This trial looks back at how patients with lymphoma were treated at Nimes University Hospital between 1999 and 2018. It aims to better understand the disease and improve care by studying stored tumor samples.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with lymphoma at Nimes University Hospital in France.
- Your diagnosis was made in 1999 or later.
- You were at least 15 years and 3 months old at the time of diagnosis.
- A sample of your tumor is still available for research.
- You (or your legal representative if you're under 18) have not said you want to opt out of the study.
- You are not currently under legal guardianship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information about people who have been treated for lung or chest cancers at Lyon University Hospital. Your data may help researchers better understand these cancers and improve future care.
This trial is a national registry that collects information about people with lymphangioleiomyomatosis to better understand the condition and care over time. It may help by contributing real-world data from patients with sporadic disease or related tuberous sclerosis.
This study follows adults who are being checked for a possible blood cancer, or who were recently diagnosed with a blood cancer within the last 6 months. It may help doctors understand the condition better and improve how early workups and care are organized.
This study is for adults newly diagnosed with lymphoma in the last 3 months, including those who may have started treatment. It aims to collect information on patients in Italy.
This study collects “real-world” health information about adults whose lymphoma was diagnosed within the last 6 months. It aims to better understand lymphoma types and how patients do over time, using data from everyday care rather than testing a new drug.
This study tracks people newly diagnosed with non-Hodgkin lymphoma to learn more about the disease and how treatments work. It helps doctors improve future care by collecting real-world data.
Hear when a new Lymphoma, Malignant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.